Anastrozole — when (and when not) to use it.

Anastrozole (brand name Arimidex) is an oral non-steroidal aromatase inhibitor. Originally FDA-approved for hormone- receptor-positive breast cancer in post-menopausal women, it is used off-label in men's health to blunt the testosterone- to-estradiol conversion that aromatase performs in adipose tissue, liver, and gonads.

Vektor prescribes it only when labs and symptoms together indicate it's warranted — not as a default TRT add-on. Estradiol has important roles in bone density, libido, lipids, and mood in men; suppressing it indiscriminately causes more problems than it solves.

Aromatase is the enzyme that converts androgens (testosterone, androstenedione) into estrogens (estradiol, estrone). Anastrozole binds the aromatase active site and reversibly inhibits it, lowering circulating estradiol.

The clinical question is never “is estradiol high?” in isolation — it's “is estradiol high and is the patient symptomatic?” Symptomatic high-E2 looks like nipple tenderness, water retention, mood lability, or libido drop. In the absence of those symptoms, mildly elevated E2 on TRT is usually a feature, not a bug.

Anastrozole tends to fit:

• TRT patients with both lab-confirmed elevated E2 and classic high-estradiol symptoms (nipple tenderness, edema, mood swings)
• Patients with higher adipose tissue who convert more aggressively
• Patients on higher T doses where E2 has clearly outpaced the therapeutic window

It does not fit patients with a single mildly-elevated E2 reading and no symptoms. Crashing estradiol causes joint pain, libido loss, and lipid issues — the opposite of what TRT is supposed to do.

Typical clinical use: 0.25–0.5mg orally, 1–2× per week, dosed opposite to the testosterone injection. Some patients respond to as little as 0.125mg. The goal is a sensitive estradiol in the mid-reference range — usually 20–40 pg/mL on the standard assay, not the suppressed levels you sometimes see prescribed.

Lab follow-up at 6–8 weeks after starting or adjusting. E2 should always be measured via the LC-MS/MS “sensitive” assay — standard immunoassay overestimates E2 in men and leads to over-treatment.

When indicated and dosed correctly: symptomatic relief (nipple/mood) within 1–2 weeks, lab confirmation at 6–8 weeks. When over-dosed: joint pain, dry skin, dropping libido, lipid worsening — call us, we'll back the dose down.

Two principles. First: we don't prescribe anastrozole prophylactically. Most TRT patients never need it. Second: when we do prescribe it, we use the sensitive E2 assay and titrate to symptoms — not to a number in isolation. Pharmacy: standard generic anastrozole from a U.S. retail or compounding pharmacy.